|
|
|
Corporate Profile: GW Pharmaceuticals
| Summary: |
GW Pharmaceuticals is focused on the research and development of cannabinoids, initially for the treatment of patients with multiple sclerosis and pain.
|
| Address (HQ): |
Porton Down Science Park
Salisbury, SP4 0JQ
United Kingdom |
| Phone
#'s (HQ): |
| Main |
+44 (0) 1980 557000 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
+44 (0) 1980 557111 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| GWPH |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
